Incidence of mefA and mefE Genes in Viridans Group Streptococci
- 1 September 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (9) , 2335-2336
- https://doi.org/10.1128/aac.43.9.2335
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Presence of mefA and mefE genes in Streptococcus agalactiae.1999
- Presence of mefA and mefE Genes in Streptococcus agalactiaeAntimicrobial Agents and Chemotherapy, 1999
- Prevalence and Characterization of the Mechanisms of Macrolide, Lincosamide, and Streptogramin Resistance in Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1998
- Different Erythromycin Resistance Mechanisms in Group C and Group G StreptococciAntimicrobial Agents and Chemotherapy, 1998
- Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiaeAntimicrobial Agents and Chemotherapy, 1997
- mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1997
- High incidence of erythromycin-resistant streptococci in TaiwanAntimicrobial Agents and Chemotherapy, 1997
- Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenesMolecular Microbiology, 1996
- Detection of erythromycin-resistant determinants by PCRAntimicrobial Agents and Chemotherapy, 1996
- In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patientsAntimicrobial Agents and Chemotherapy, 1996